prev next front |1 |2 |3 |4 |5 |6 |7 |8 |9 |10 |11 |12 |13 |14 |15 |16 |17 |18 |19 |20 |21 |22 |23 |24 | 25|26 |27 |28 |29 |30 |31 |32 |33 |34 |35 |36 |37 |38 |39 |40 |review
Twenty-nine of 33 sera from children experiencing a silent dengue infection neutralized dengue 2 in human monocyte cultures; 6 of 7 sera from children experiencing overt disease enhanced or failed to neutralize dengue 2 virus. Children with high levels of heterotypic neutralizing antibodies were protected from severe disease accompanying secondary dengue infections. Heterotypic antibodies provide partial, not complete protection.